ANIP - ANI Pharmaceuticals EPS beats by $0.31 beats on revenue
ANI Pharmaceuticals (NASDAQ:ANIP): Q3 Non-GAAP EPS of $1.01 beats by $0.31; GAAP EPS of -$0.37 misses by $0.16. Revenue of $52.06M (-1.7% Y/Y) beats by $2.36M. Shares +5.40% PM. Press Release
For further details see:
ANI Pharmaceuticals EPS beats by $0.31, beats on revenue